๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Tongliao
Clinical trial register · China

Clinical Trials in Tongliao, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Tongliao

5 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer
NCT07712094Neuroendocrine Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2
56
Baotou, Tongliao, Taiyuan, Tianjin
2026-08-01
Recruiting
Polypills Approach for Multiple Cardiovascular Risk Factors
NCT07679828Hypertension, Dyslipidemia, Diabetes
China Medical University, China
Not applicable
8,252
Zhengzhou, Chifeng, Tongliao, Kunshan, Suzhou, Taizhou, Jinzhou, Panjin
2026-07-11
Recruiting
IMPACT COPD Cohort (China)
NCT07382986Chronic Obstructive Pulmonary Disease (COPD), Multimorbidities
Beijing Chao Yang Hospital
Observational
10,000
Hebi, Tongliao, Mianyang, Shihezi
2026-02-26
Active, closed
Community Smart Aging Model - Resistance Training
NCT07506538Primary Osteoporosis
Lingshu Sun
Not applicable
98
Tongliao
2025-08-01
Recruiting
Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial
NCT04948749ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis, Drug-eluting Stent, Stroke
Beijing Tiantan Hospital
Not applicable
358
Beijing, Cangzhou, Tangshan, Xingtai, Wuhan, Baotou, Hohhot, Tongliao
2021-07-02
Rows per page Showing 1–5 of 5
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/tongliao

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5 of those studies with a site in Tongliao.

How many clinical trials are recruiting in Tongliao?

3 of the 5 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Tongliao), 5 studies
PhaseStudiesRecruitingShare
Not applicable3260%
Observational1120%
Phase 21020%

Most active sponsors

Lead sponsors with the most studies (Tongliao)
Lead sponsorStudiesRecruiting
Beijing Chao Yang Hospital11
Beijing Tiantan Hospital11
China Medical University, China11
Lingshu Sun10
Tianjin Medical University Cancer Institute and Hospital10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.